Trials / Recruiting
RecruitingNCT06694636
Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Zhongda Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients who met the inclusion criteria were treated with endovascular radiofrequency ablation and desympathetic nerve surgery. After enrollment, endovascular radiofrequency ablation and desympathetic surgery were performed. After radiofrequency ablation, the safety and efficacy of follow-up treatment will be carried out every 1 month or so, including blood routine, liver and kidney function, tumor indicators, abdominal CT/magnetic resonance, etc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | endovascular radiofrequency ablation and desympathetic nerve surgery | endovascular radiofrequency ablation and desympathetic nerve surgery |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2024-11-19
- Last updated
- 2024-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06694636. Inclusion in this directory is not an endorsement.